Berrak Eryasa1, Philippe Grandjean2, Flemming Nielsen3, Damaskini Valvi4, Denis Zmirou-Navier5, Elsie Sunderland6, Pal Weihe7, Youssef Oulhote8. 1. Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA, United States of America; EHESP-School of Public Health, Sorbonne Paris Cité, Rennes, France. 2. Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA, United States of America; University of Southern Denmark, Odense, Denmark. 3. University of Southern Denmark, Odense, Denmark. 4. Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA, United States of America. 5. EHESP-School of Public Health, Sorbonne Paris Cité, Rennes, France. 6. Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA, United States of America; Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, MA, United States of America. 7. The Faroese Hospital System, Tórshavn, Faroe Islands. 8. Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA, United States of America; Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts at Amherst, Amherst, MA, United States of America. Electronic address: youlhote@umass.edu.
Abstract
BACKGROUND: Per- and polyfluoroalkyl substances (PFASs) are a growing public health concern. Some longer chain PFASs bioaccumulate and many compounds persist in the environment for long time periods. Recent studies have established their ability to pass through placenta, yet data on the transplacental transfer efficiency and partitioning of short and long chain PFASs in blood matrices are limited. OBJECTIVES: To assess predictors of the partitioning of 17 PFAS compounds detected in the maternal serum, umbilical cord serum and whole cord blood samples from matched mother-newborn pairs from two Faroe Islands cohorts. METHODS: We examined 151 mother-newborn pairs from two successive Faroese birth cohorts. Cord:maternal serum (transplacental transfer) and serum:whole cord blood (blood partitioning) ratios were estimated for 17 PFAS compounds. We also examined the relationships of these ratios with maternal, newborns', and physico-chemical properties using multivariable regression analyses. RESULTS: Moderate to high correlations were observed between maternal and cord serum PFAS concentrations (ρ: 0.41 to 0.95), indicating significant transfer of these compounds from the mother to the fetus. Median transplacental transfer ratios were generally below 1, except for perfluorooctane sulfonamide (FOSA), and ranged between 0.36 for perfluorodecanoate (PFDA) and perfluoroundecanoate (PFUnDA) and 1.21 for FOSA. Most PFASs exhibited a preference to the serum component of the blood, except FOSA and perfluoroheptanoate (PFHpA), with blood partitioning ratios ranging from 0.36 for FOSA to 2.75 for PFUnDA. Both the functional groups and carbon chain length of different PFASs were important predictors of transplacental transfer and blood partitioning. We observed a U-shaped relationship between transplacental transfer ratios and carbon chain length for perfluorocarboxylates and perfluorosulfonates. Importantly, gestational diabetes was also a strong predictor of transplacental transfer ratios, with significantly higher transfer in mothers with gestational diabetes. CONCLUSIONS: Our findings provide a better understanding of the transplacental transfer and blood partitioning of a large number of PFAS compounds. Results elucidate the importance of chemical structure for future risk assessments and choice of appropriate blood matrices for measurement of PFAS compounds.
BACKGROUND:Per- and polyfluoroalkyl substances (PFASs) are a growing public health concern. Some longer chain PFASs bioaccumulate and many compounds persist in the environment for long time periods. Recent studies have established their ability to pass through placenta, yet data on the transplacental transfer efficiency and partitioning of short and long chain PFASs in blood matrices are limited. OBJECTIVES: To assess predictors of the partitioning of 17 PFAS compounds detected in the maternal serum, umbilical cord serum and whole cord blood samples from matched mother-newborn pairs from two Faroe Islands cohorts. METHODS: We examined 151 mother-newborn pairs from two successive Faroese birth cohorts. Cord:maternal serum (transplacental transfer) and serum:whole cord blood (blood partitioning) ratios were estimated for 17 PFAS compounds. We also examined the relationships of these ratios with maternal, newborns', and physico-chemical properties using multivariable regression analyses. RESULTS: Moderate to high correlations were observed between maternal and cord serum PFAS concentrations (ρ: 0.41 to 0.95), indicating significant transfer of these compounds from the mother to the fetus. Median transplacental transfer ratios were generally below 1, except for perfluorooctane sulfonamide (FOSA), and ranged between 0.36 for perfluorodecanoate (PFDA) and perfluoroundecanoate (PFUnDA) and 1.21 for FOSA. Most PFASs exhibited a preference to the serum component of the blood, except FOSA and perfluoroheptanoate (PFHpA), with blood partitioning ratios ranging from 0.36 for FOSA to 2.75 for PFUnDA. Both the functional groups and carbon chain length of different PFASs were important predictors of transplacental transfer and blood partitioning. We observed a U-shaped relationship between transplacental transfer ratios and carbon chain length for perfluorocarboxylates and perfluorosulfonates. Importantly, gestational diabetes was also a strong predictor of transplacental transfer ratios, with significantly higher transfer in mothers with gestational diabetes. CONCLUSIONS: Our findings provide a better understanding of the transplacental transfer and blood partitioning of a large number of PFAS compounds. Results elucidate the importance of chemical structure for future risk assessments and choice of appropriate blood matrices for measurement of PFAS compounds.
Authors: Anders Glynn; Urs Berger; Anders Bignert; Shahid Ullah; Marie Aune; Sanna Lignell; Per Ola Darnerud Journal: Environ Sci Technol Date: 2012-08-10 Impact factor: 9.028
Authors: Tao Zhang; Qian Wu; Hong Wen Sun; Xian Zhong Zhang; Se Hun Yun; Kurunthachalam Kannan Journal: Environ Sci Technol Date: 2010-06-01 Impact factor: 9.028
Authors: P Grandjean; P Weihe; L L Needham; V W Burse; D G Patterson; E J Sampson; P J Jørgensen; M Vahter Journal: Environ Res Date: 1995-10 Impact factor: 6.498
Authors: Hermann Fromme; Sheryl A Tittlemier; Wolfgang Völkel; Michael Wilhelm; Dorothee Twardella Journal: Int J Hyg Environ Health Date: 2008-06-18 Impact factor: 5.840
Authors: Jacqueline Bangma; T C Guillette; Paige A Bommarito; Carla Ng; Jessica L Reiner; Andrew B Lindstrom; Mark J Strynar Journal: Environ Int Date: 2021-12-09 Impact factor: 9.621
Authors: Julia E Rager; Jacqueline Bangma; Celeste Carberry; Alex Chao; Jarod Grossman; Kun Lu; Tracy A Manuck; Jon R Sobus; John Szilagyi; Rebecca C Fry Journal: Reprod Toxicol Date: 2020-02-23 Impact factor: 3.143
Authors: Annelise J Blomberg; Yu-Hsuan Shih; Carmen Messerlian; Louise Helskov Jørgensen; Pál Weihe; Philippe Grandjean Journal: Environ Res Date: 2021-05-31 Impact factor: 8.431
Authors: Rahel L Birru; Hai-Wei Liang; Fouzia Farooq; Megha Bedi; Maisa Feghali; Catherine L Haggerty; Dara D Mendez; Janet M Catov; Carla A Ng; Jennifer J Adibi Journal: Environ Health Date: 2021-05-22 Impact factor: 7.123
Authors: Suzanne E Fenton; Alan Ducatman; Alan Boobis; Jamie C DeWitt; Christopher Lau; Carla Ng; James S Smith; Stephen M Roberts Journal: Environ Toxicol Chem Date: 2020-12-07 Impact factor: 4.218